Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 6Refractory Solid Tumors 3Advanced Solid Tumors 3Solid Tumors 2Mesothelioma 2Unspecified Adult Solid Tumor 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1SOLID TUMORS 1Relapsed Pediatric Solid Tumor 1Prostatic Neoplasms 1Pediatric Solid Tumors 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Lung Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Advanced Solid Tumor 1

Interventions

TIC10 compound 1Sorafenib 1Radiosurgery 1Pemetrexed 1Imatinib Mesylate 1Cyclophosphamide 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unspecified Adult Solid Tumor × Sorafenib × Other solid neoplasm × Clear all
NCT01450384 2016-02-23

Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors

Virginia Commonwealth University

Phase 1 Completed
37 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡